Wednesday 28 December 2011

Apo-Nizatidine




Apo-Nizatidine may be available in the countries listed below.


Ingredient matches for Apo-Nizatidine



Nizatidine

Nizatidine is reported as an ingredient of Apo-Nizatidine in the following countries:


  • Canada

  • Guyana

International Drug Name Search

Monday 26 December 2011

Somnopentyl




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Somnopentyl



Pentobarbital

Pentobarbital sodium salt (a derivative of Pentobarbital) is reported as an ingredient of Somnopentyl in the following countries:


  • United States

International Drug Name Search

Sunday 25 December 2011

Poloxamère




Poloxamère may be available in the countries listed below.


Ingredient matches for Poloxamère



Poloxamer

Poloxamère (DCF) is also known as Poloxamer (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 23 December 2011

Cetirrinol




Cetirrinol may be available in the countries listed below.


Ingredient matches for Cetirrinol



Cetirizine

Cetirizine is reported as an ingredient of Cetirrinol in the following countries:


  • Colombia

International Drug Name Search

SSD




In the US, SSD (silver sulfadiazine topical) is a member of the drug class topical antibiotics and is used to treat Burns, External.

US matches:

  • SSD

  • SSD AF

  • SSD AF Topical

  • Ssd Topical

Ingredient matches for SSD



Sulfadiazine

Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of SSD in the following countries:


  • United States

International Drug Name Search

Thursday 22 December 2011

Avapena




Avapena may be available in the countries listed below.


Ingredient matches for Avapena



Chloropyramine

Chloropyramine hydrochloride (a derivative of Chloropyramine) is reported as an ingredient of Avapena in the following countries:


  • Mexico

International Drug Name Search

Sunday 18 December 2011

Fosinopril Interpharm




Fosinopril Interpharm may be available in the countries listed below.


Ingredient matches for Fosinopril Interpharm



Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Fosinopril Interpharm in the following countries:


  • Austria

International Drug Name Search

Saturday 17 December 2011

Tonotensil




Tonotensil may be available in the countries listed below.


Ingredient matches for Tonotensil



Lisinopril

Lisinopril is reported as an ingredient of Tonotensil in the following countries:


  • Chile

International Drug Name Search

Friday 16 December 2011

Natriumvalproat Hexal




Natriumvalproat Hexal may be available in the countries listed below.


Ingredient matches for Natriumvalproat Hexal



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Natriumvalproat Hexal in the following countries:


  • Austria

International Drug Name Search

Synerpen




Synerpen may be available in the countries listed below.


Ingredient matches for Synerpen



Ampicillin

Ampicillin is reported as an ingredient of Synerpen in the following countries:


  • Ethiopia

Benzylpenicillin

Benzylpenicillin is reported as an ingredient of Synerpen in the following countries:


  • Ethiopia

Sulbactam

Sulbactam is reported as an ingredient of Synerpen in the following countries:


  • Ethiopia

International Drug Name Search

Wednesday 14 December 2011

Doxazosin Mesilate




Doxazosin Mesilate may be available in the countries listed below.


Ingredient matches for Doxazosin Mesilate



Doxazosin

Doxazosin Mesilate (BANM) is known as Doxazosin in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 12 December 2011

Clotiapine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AH06

CAS registry number (Chemical Abstracts Service)

0002058-52-8

Chemical Formula

C18-H18-Cl-N3-S

Molecular Weight

343

Therapeutic Category

Neuroleptic

Chemical Name

Dibenzo[b,f][1,4]thiazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-

Foreign Names

  • Clotiapinum (Latin)
  • Clotiapin (German)
  • Clotiapine (French)
  • Clotiapina (Spanish)

Generic Names

  • Clothiapine (OS: USAN)
  • Clotiapina (OS: DCIT)
  • Clotiapine (OS: BAN, DCF)
  • HF 2159 (IS)
  • LW-2159 (IS)
  • W 130 (IS)

Brand Names

  • Entumin
    Novartis, Switzerland; Novartis, Ghana; Novartis, Israel; Novartis, Italy; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, Sudan; Novartis, Tanzania; Novartis, Zimbabwe


  • Etomine
    Novartis, South Africa


  • Etumina
    Novartis, Argentina; Novartis, Spain


  • Etumine
    Novartis, Belgium; Novartis, Taiwan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 7 December 2011

Roacutane




Roacutane may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Roacutane



Isotretinoin

Isotretinoin is reported as an ingredient of Roacutane in the following countries:


  • United Kingdom

International Drug Name Search

Monday 28 November 2011

Bytrite




Bytrite may be available in the countries listed below.


Ingredient matches for Bytrite



Ramipril

Ramipril is reported as an ingredient of Bytrite in the following countries:


  • Ireland

International Drug Name Search

Wednesday 23 November 2011

Enam




Enam may be available in the countries listed below.


Ingredient matches for Enam



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enam in the following countries:


  • Bahrain

  • Myanmar

  • Peru

  • Russian Federation

  • Sri Lanka

  • Venezuela

International Drug Name Search

Monday 21 November 2011

Dilaudid


See also: Generic Dilaudid-HP


Dilaudid is a brand name of hydromorphone, approved by the FDA in the following formulation(s):


DILAUDID (hydromorphone hydrochloride - injectable; injection)



  • Manufacturer: PURDUE PHARM PRODS

    Approval date: April 30, 2009

    Strength(s): 1MG/ML [RLD][AP], 2MG/ML [RLD][AP], 4MG/ML [RLD][AP]

DILAUDID (hydromorphone hydrochloride - solution; oral)



  • Manufacturer: PURDUE PHARM PRODS

    Approval date: December 7, 1992

    Strength(s): 5MG/5ML [RLD][AA]

DILAUDID (hydromorphone hydrochloride - tablet; oral)



  • Manufacturer: PURDUE PHARM PRODS

    Approval date: December 7, 1992

    Strength(s): 8MG [RLD][AB]


  • Manufacturer: PURDUE PHARM PRODS

    Approval date: November 9, 2007

    Strength(s): 2MG [AB], 4MG [AB]

Has a generic version of Dilaudid been approved?


A generic version of Dilaudid has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Dilaudid and have been approved by the FDA:


hydromorphone hydrochloride injectable; injection



  • Manufacturer: HOSPIRA INC

    Approval date: December 1, 2011

    Strength(s): 1MG/ML [AP], 2MG/ML [AP], 4MG/ML [AP]

hydromorphone hydrochloride solution; oral



  • Manufacturer: ROXANE

    Approval date: July 29, 1998

    Strength(s): 5MG/5ML [AA]

hydromorphone hydrochloride tablet; oral



  • Manufacturer: ELITE LABS

    Approval date: October 18, 2005

    Strength(s): 8MG [AB]


  • Manufacturer: LANNETT

    Approval date: December 9, 2009

    Strength(s): 2MG [AB], 4MG [AB], 8MG [AB]


  • Manufacturer: MALLINCKRODT

    Approval date: December 23, 2004

    Strength(s): 8MG [AB]


  • Manufacturer: MALLINCKRODT INC

    Approval date: September 19, 2007

    Strength(s): 2MG [AB], 4MG [AB]


  • Manufacturer: NESHER PHARMS

    Approval date: November 9, 2005

    Strength(s): 2MG [AB], 4MG [AB], 8MG [AB]


  • Manufacturer: ROXANE

    Approval date: July 29, 1998

    Strength(s): 8MG [AB]


  • Manufacturer: ROXANE

    Approval date: May 29, 2009

    Strength(s): 4MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dilaudid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Hydromorphone and hydrocodone compositions and methods for their synthesis
    Patent 6,589,960
    Issued: July 8, 2003
    Inventor(s): William H.; Harclerode & Robert; Gault & Mark D.; Sandison
    Assignee(s): Abbott Laboratories
    A method for the preparation of a ketone from a narcotic alkaloid having an allyl alcohol moiety is disclosed. The method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the substantial absence of hydrogen gas. The method is useful for preparing hydromorphone and hydrocodone compositions having novel impurity profiles. Compositions comprising hydromorphone and hydrocodone are also disclosed.
    Patent expiration dates:

    • November 9, 2020
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Dilaudid Consumer Information (Drugs.com)
  • Dilaudid Consumer Information (Wolters Kluwer)
  • Dilaudid Liquid Consumer Information (Wolters Kluwer)
  • Dilaudid Suppository Consumer Information (Wolters Kluwer)
  • Dilaudid Tablets Consumer Information (Wolters Kluwer)
  • Dilaudid Consumer Information (Cerner Multum)
  • Dilaudid injection Consumer Information (Cerner Multum)
  • Dilaudid rectal Consumer Information (Cerner Multum)
  • Dilaudid-5 Consumer Information (Cerner Multum)
  • Dilaudid Advanced Consumer Information (Micromedex)
  • Dilaudid Injection Advanced Consumer Information (Micromedex)
  • Dilaudid-5 Advanced Consumer Information (Micromedex)
  • Hydromorphone Consumer Information (Wolters Kluwer)
  • Hydromorphone Extended-Release Consumer Information (Wolters Kluwer)
  • Hydromorphone Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Hydromorphone High-Potency Consumer Information (Wolters Kluwer)
  • Hydromorphone Liquid Consumer Information (Wolters Kluwer)
  • Hydromorphone Suppository Consumer Information (Wolters Kluwer)
  • Hydromorphone Tablets Consumer Information (Wolters Kluwer)
  • Hydromorphone Consumer Information (Cerner Multum)
  • Hydromorphone injection Consumer Information (Cerner Multum)
  • Hydromorphone rectal Consumer Information (Cerner Multum)
  • Hydromorphone Advanced Consumer Information (Micromedex)
  • Hydromorphone Injection Advanced Consumer Information (Micromedex)
  • Hydromorphone Hydrochloride AHFS DI Monographs (ASHP)

Saturday 19 November 2011

Cerazet




Cerazet may be available in the countries listed below.


Ingredient matches for Cerazet



Desogestrel

Desogestrel is reported as an ingredient of Cerazet in the following countries:


  • Iceland

  • Spain

International Drug Name Search

Monday 14 November 2011

Prevpac


Prevpac is a brand name of amoxicillin/clarithromycin/lansoprazole, approved by the FDA in the following formulation(s):


PREVPAC (amoxicillin; clarithromycin; lansoprazole - capsule, tablet, capsule, delayed rel pellets; oral)



  • Manufacturer: TAKEDA PHARMS NA

    Approval date: December 2, 1997

    Strength(s): 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30MG [RLD]

Has a generic version of Prevpac been approved?


No. There is currently no therapeutically equivalent version of Prevpac available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prevpac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Prevpac.

See also...

  • Prevpac Therapy Pack Consumer Information (Wolters Kluwer)
  • Prevpac Consumer Information (Cerner Multum)
  • Amoxicillin/Clarithromycin/Lansoprazole Therapy Pack Consumer Information (Wolters Kluwer)
  • Amoxicillin, clarithromycin, and lansoprazole Consumer Information (Cerner Multum)

Friday 11 November 2011

Solupen




Solupen may be available in the countries listed below.


Ingredient matches for Solupen



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Solupen in the following countries:


  • Ethiopia

Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Solupen in the following countries:


  • Germany

International Drug Name Search

Nobecid




Nobecid may be available in the countries listed below.


Ingredient matches for Nobecid



Ampicillin

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Nobecid in the following countries:


  • Turkey

Sulbactam

Sulbactam sodium salt (a derivative of Sulbactam) is reported as an ingredient of Nobecid in the following countries:


  • Turkey

Sultamicillin

Sultamicillin is reported as an ingredient of Nobecid in the following countries:


  • Turkey

International Drug Name Search

Sunday 6 November 2011

Cozaar Plus




Cozaar Plus may be available in the countries listed below.


Ingredient matches for Cozaar Plus



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Cozaar Plus in the following countries:


  • Netherlands

  • Spain

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Cozaar Plus in the following countries:


  • Netherlands

  • Spain

International Drug Name Search

Saturday 5 November 2011

Smecta




Smecta may be available in the countries listed below.


Ingredient matches for Smecta



Diosmectite

Diosmectite is reported as an ingredient of Smecta in the following countries:


  • Bulgaria

  • Croatia (Hrvatska)

  • Czech Republic

  • Estonia

  • France

  • Georgia

  • Hong Kong

  • Hungary

  • Latvia

  • Lithuania

  • Luxembourg

  • Malaysia

  • Poland

  • Romania

  • Russian Federation

  • Serbia

  • Singapore

  • Slovakia

  • Tunisia

  • Vietnam

Montmorillonite

Montmorillonite is reported as an ingredient of Smecta in the following countries:


  • China

International Drug Name Search

Friday 4 November 2011

Anasolde




Anasolde may be available in the countries listed below.


Ingredient matches for Anasolde



Anastrozole

Anastrozole is reported as an ingredient of Anasolde in the following countries:


  • Poland

International Drug Name Search

Monday 31 October 2011

Sumatab




Sumatab may be available in the countries listed below.


Ingredient matches for Sumatab



Sumatriptan

Sumatriptan succinate (a derivative of Sumatriptan) is reported as an ingredient of Sumatab in the following countries:


  • Australia

International Drug Name Search

Friday 28 October 2011

Erbitux




In the US, Erbitux (cetuximab systemic) is a member of the drug class EGFR inhibitors and is used to treat Colorectal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer and Squamous Cell Carcinoma.

US matches:

  • Erbitux

UK matches:

  • Erbitux 5mg/ml solution for infusion (SPC)

Ingredient matches for Erbitux



Cetuximab

Cetuximab is reported as an ingredient of Erbitux in the following countries:


  • Argentina

  • Australia

  • Austria

  • Bahrain

  • Belgium

  • Bulgaria

  • Canada

  • Chile

  • China

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Egypt

  • Finland

  • France

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Iran

  • Iraq

  • Ireland

  • Israel

  • Italy

  • Jordan

  • Kuwait

  • Lebanon

  • Luxembourg

  • Malaysia

  • Mexico

  • Netherlands

  • New Zealand

  • Norway

  • Oman

  • Peru

  • Philippines

  • Qatar

  • Saudi Arabia

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Syria

  • Taiwan

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 25 October 2011

Iodinã




Iodinã may be available in the countries listed below.


Ingredient matches for Iodinã



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Iodinã in the following countries:


  • Romania

International Drug Name Search

Choragon




Choragon may be available in the countries listed below.


UK matches:

  • Choragon 5000 U and Choragon Solvent (SPC)

Ingredient matches for Choragon



Chorionic Gonadotrophin

Chorionic Gonadotrophin is reported as an ingredient of Choragon in the following countries:


  • Bahrain

  • Belgium

  • Egypt

  • Hong Kong

  • Hungary

  • Ireland

  • Jordan

  • Kuwait

  • Lebanon

  • Malaysia

  • Malta

  • Mexico

  • Poland

  • Qatar

  • Saudi Arabia

  • Slovakia

  • Syria

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 24 October 2011

Cardene




In the US, Cardene (nicardipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Angina Pectoris Prophylaxis, Heart Failure and High Blood Pressure.

US matches:

  • Cardene

  • Cardene IV

  • Cardene SR Sustained-Release Capsules

  • Cardene SR

  • Cardene Intravenous

  • Cardene Injection

UK matches:

  • Cardene 20mg and 30mg capsules
  • Cardene 20 and 30mg (SPC)
  • Cardene SR 30 and 45mg (SPC)

Ingredient matches for Cardene



Nicardipine

Nicardipine hydrochloride (a derivative of Nicardipine) is reported as an ingredient of Cardene in the following countries:


  • Netherlands

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 22 October 2011

Capivit A+E




Capivit A+E may be available in the countries listed below.


Ingredient matches for Capivit A+E



Retinol

Retinol acetate (a derivative of Retinol) is reported as an ingredient of Capivit A+E in the following countries:


  • Slovenia

Tocopherol, α-

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Capivit A+E in the following countries:


  • Slovenia

International Drug Name Search

Alcohol Yodado




Alcohol Yodado may be available in the countries listed below.


Ingredient matches for Alcohol Yodado



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Alcohol Yodado in the following countries:


  • Peru

International Drug Name Search

Saturday 15 October 2011

Ibuprofeno Korhispana




Ibuprofeno Korhispana may be available in the countries listed below.


Ingredient matches for Ibuprofeno Korhispana



Ibuprofen

Ibuprofen is reported as an ingredient of Ibuprofeno Korhispana in the following countries:


  • Spain

International Drug Name Search

Tuesday 11 October 2011

Sacin




Sacin may be available in the countries listed below.


Ingredient matches for Sacin



Amfepramone

Amfepramone is reported as an ingredient of Sacin in the following countries:


  • Chile

International Drug Name Search

Monday 10 October 2011

Diaphyllin Venosum




Diaphyllin Venosum may be available in the countries listed below.


Ingredient matches for Diaphyllin Venosum



Aminophylline

Aminophylline is reported as an ingredient of Diaphyllin Venosum in the following countries:


  • Hungary

International Drug Name Search

Sunday 9 October 2011

Ticarcillin




In some countries, this medicine may only be approved for veterinary use.


In the US, Ticarcillin (ticarcillin systemic) is a member of the drug class antipseudomonal penicillins and is used to treat Bone infection, Febrile Neutropenia, Intraabdominal Infection, Joint Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Septicemia, Skin Infection and Urinary Tract Infection.

US matches:

  • Ticarcillin

  • Ticarcillin/Clavulanate

  • Ticarcillin and clavulanate potassium injection

  • Ticarcillin and clavulanate Intravenous

  • Ticarcillin Disodium and Clavulanate Potassium

  • Ticarcillin/Clavulanate Potassium

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01CA13

CAS registry number (Chemical Abstracts Service)

0034787-01-4

Chemical Formula

C15-H16-N2-O6-S2

Molecular Weight

384

Therapeutic Category

Antibacterial: Penicillin, broad-spectrum

Chemical Name

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxy-3-thienylacetyl)amino]-3,3-dimethyl-7-oxo-, [2S-[2α,5α,6ß(S*)]]-

Foreign Names

  • Ticarcillinum (Latin)
  • Ticarcillin (German)
  • Ticarcilline (French)
  • Ticarcilina (Spanish)

Generic Names

  • Ticarcillin (OS: BAN)
  • Ticarcillina (OS: DCIT)
  • Ticarcilline (OS: DCF)
  • Ticarcillin Disodium (OS: USAN)
  • Ticarcillin Sodium (OS: BANM, JAN)
  • BRL 2288 (IS: Beecham)
  • Ticarcillin Disodium (PH: USP 32)
  • Ticarcillin Sodium (PH: BP 2010, JP XIV, Ph. Eur. 6)
  • Ticarcilline sodique (PH: Ph. Eur. 6)
  • Ticarcillin-Natrium (PH: Ph. Eur. 6)
  • Ticarcillinum natricum (PH: Ph. Eur. 6)

Brand Names

  • Ticarpen
    GlaxoSmithKline, Tunisia


  • Claventin (Ticarcillin and Clavulanic Acid)
    GlaxoSmithKline, France


  • Ticarpen
    GlaxoSmithKline, France; SmithKline Beecham, Spain


  • Ticillin (veterinary use)
    Pfizer Animal Health, United States


  • Timentin (Ticarcillin and Clavulanic Acid potassium salt)
    GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Brazil; GlaxoSmithKline, Canada; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iran; GlaxoSmithKline, Italy; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 5 October 2011

Centilux




Centilux may be available in the countries listed below.


Ingredient matches for Centilux



Methylthioninium Chloride

Methylthioninium Chloride is reported as an ingredient of Centilux in the following countries:


  • Spain

Naphazoline

Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Centilux in the following countries:


  • Spain

International Drug Name Search

Monday 26 September 2011

Suldimet




Suldimet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Suldimet



Sulfadimethoxine

Sulfadimethoxine is reported as an ingredient of Suldimet in the following countries:


  • Italy

International Drug Name Search

Sunday 25 September 2011

Ceftriaxona Sandoz




Ceftriaxona Sandoz may be available in the countries listed below.


Ingredient matches for Ceftriaxona Sandoz



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ceftriaxona Sandoz in the following countries:


  • Spain

International Drug Name Search

Saturday 24 September 2011

Flector Patch


Flector Patch is a brand name of diclofenac topical, approved by the FDA in the following formulation(s):


FLECTOR (diclofenac epolamine - patch; topical)



  • Manufacturer: INST BIOCHEM

    Approval date: January 31, 2007

    Strength(s): 1.3% [RLD]

Has a generic version of Flector Patch been approved?


No. There is currently no therapeutically equivalent version of Flector Patch available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Flector Patch. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • External anti-inflammatory and analgesic plaster preparation
    Patent 5,607,690
    Issued: March 4, 1997
    Inventor(s): Akazawa; Mitsuji
    Assignee(s): Teikoku Seiyaku Co., Ltd.
    Altergon S.A.
    An external anti-inflammatory and analgesic plaster preparation includes as an active ingredient a salt of diclofenac, 2[(2,6-dichlorophenyl)amino]benzene-acetic acid, with a cyclic organic having the general formula (I): ##STR1## wherein X is a group of the formula --(CH.sub.2)m-- in which m is an integer of 0 or 1 and n is an integer of 2 and a pH value of the preparation is adjusted to a range of 7.3 to 9.0.
    Patent expiration dates:

    • April 13, 2014
      ✓ 
      Drug product



See also...

  • Flector Consumer Information (Drugs.com)
  • Flector Patch Consumer Information (Wolters Kluwer)
  • Flector Patch Consumer Information (Cerner Multum)
  • Flector Topical Advanced Consumer Information (Micromedex)
  • Diclofenac Gel Consumer Information (Wolters Kluwer)
  • Diclofenac Patch Consumer Information (Wolters Kluwer)
  • Diclofenac Solution Consumer Information (Wolters Kluwer)
  • Diclofenac topical Consumer Information (Cerner Multum)
  • Diclofenac transdermal Consumer Information (Cerner Multum)
  • Voltaren Topical Advanced Consumer Information (Micromedex)
  • Diclofenac Topical Advanced Consumer Information (Micromedex)
  • Diclofenac Sodium topical AHFS DI Monographs (ASHP)

Wednesday 21 September 2011

Sulbactam Hexal




Sulbactam Hexal may be available in the countries listed below.


Ingredient matches for Sulbactam Hexal



Sulbactam

Sulbactam sodium salt (a derivative of Sulbactam) is reported as an ingredient of Sulbactam Hexal in the following countries:


  • Germany

International Drug Name Search

Apracur




Apracur may be available in the countries listed below.


Ingredient matches for Apracur



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Apracur in the following countries:


  • Argentina

Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Apracur in the following countries:


  • Argentina

International Drug Name Search

Monday 19 September 2011

Palitrex




Palitrex may be available in the countries listed below.


Ingredient matches for Palitrex



Cefalexin

Cefalexin is reported as an ingredient of Palitrex in the following countries:


  • Serbia

International Drug Name Search

Sunday 18 September 2011

Optifen




Optifen may be available in the countries listed below.


Ingredient matches for Optifen



Ibuprofen

Ibuprofen is reported as an ingredient of Optifen in the following countries:


  • Switzerland

International Drug Name Search

Lenaberic




Lenaberic may be available in the countries listed below.


Ingredient matches for Lenaberic



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Lenaberic in the following countries:


  • Japan

International Drug Name Search

Friday 16 September 2011

Tredical




Tredical may be available in the countries listed below.


Ingredient matches for Tredical



Nimesulide

Nimesulide is reported as an ingredient of Tredical in the following countries:


  • Myanmar

International Drug Name Search

Thursday 15 September 2011

Dermarest Plus Anti-Itch


Generic Name: hydrocortisone topical (hye droe KOR ti sone)

Brand Names: Ala-Cort, Ala-Scalp HP, Aquanil HC, Beta HC, Caldecort, Cortaid, Cortaid Intensive Therapy, Cortaid Maximum Strength, Cortaid with Aloe, Cortalo with Aloe, Corticaine, Cortizone for Kids, Cortizone-10, Cortizone-10 Intensive Healing Formula, Cortizone-10 Plus, Cortizone-5, Dermarest Dricort, Dermarest Eczema Medicated, Dermarest Plus Anti-Itch, Dermtex HC, Genasone/Aloe, Gly-Cort, Gynecort Maximum Strength, Hycort, Hydrocortisone 1% In Absorbase, Hydrocortisone with Aloe, Hydrocortisone-Aloe, Hytone, Instacort, Itch-X Lotion, Locoid, Locoid Lipocream, Locoid Lotion, Massengill Medicated Soft Cloth, MD Hydrocortisone, Neutrogena T-Scalp, NuCort with Aloe, NuZon, Pandel, Recort Plus, Rederm, Sarnol-HC, Scalacort, Texacort, U-Cort, Westcort


What is Dermarest Plus Anti-Itch (hydrocortisone topical)?

Hydrocortisone is a topical steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.


Hydrocortisone topical is used to treat inflammation of the skin caused by a number of conditions such as allergic reactions, eczema, or psoriasis.


Hydrocortisone topical may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Dermarest Plus Anti-Itch (hydrocortisone topical)?


There are many brands and forms of hydrocortisone topical available and not all brands are listed on this leaflet.


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with hydrocortisone topical can increase the amount of the drug your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions.

Avoid using this medication on your face, near your eyes, or on body areas where you have skin folds or thin skin.


Do not use this medication on a child without a doctor's advice. Children are more sensitive to the effects of hydrocortisone topical.

Hydrocortisone topical will not treat a bacterial, fungal, or viral skin infection.


Contact your doctor if your condition does not improve or if it gets worse after using this medication for several days.

What should I discuss with my healthcare provider before using Dermarest Plus Anti-Itch (hydrocortisone topical)?


Do not use this medication if you are allergic to hydrocortisone.

Hydrocortisone topical will not treat a bacterial, fungal, or viral skin infection.


FDA pregnancy category C. It is not known whether hydrocortisone topical is harmful to an unborn baby. Before using this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether hydrocortisone topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child without a doctor's advice. Children are more sensitive to the effects of hydrocortisone topical.

How should I use Dermarest Plus Anti-Itch (hydrocortisone topical)?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger or smaller amounts, or use it for longer than recommended.


Hydrocortisone topical will not treat a bacterial, fungal, or viral skin infection.


Wash your hands before and after each application, unless you are using hydrocortisone topical to treat a hand condition.


Apply a small amount to the affected area and rub it gently into the skin.


Avoid using this medication on your face, near your eyes or mouth, or on body areas where you have skin folds or thin skin.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with hydrocortisone topical can increase the amount of the drug your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Contact your doctor if your condition does not improve or if it gets worse after using this medication for several days. It is important to use hydrocortisone topical regularly to get the most benefit. Store hydrocortisone topical at room temperature away from moisture and heat.

What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine, or if anyone has accidentally swallowed it. An overdose of hydrocortisone topical applied to the skin is not expected to produce life-threatening symptoms.

What should I avoid while using Dermarest Plus Anti-Itch (hydrocortisone topical)?


Avoid getting this medication in your eyes, mouth, and nose, or on your lips. If it does get into any of these areas, wash with water. Do not use hydrocortisone topical on sunburned, windburned, irritated, or broken skin. Also avoid using this medication in open wounds.

Avoid using skin products that can cause irritation, such as harsh soaps or shampoos or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.


Dermarest Plus Anti-Itch (hydrocortisone topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using hydrocortisone topical and call your doctor at once if you have any of these serious side effects:

  • blurred vision, or seeing halos around lights;




  • uneven heartbeats;




  • sleep problems (insomnia);




  • weight gain, puffiness in your face; or




  • feeling tired.



Less serious side effects may include:



  • skin redness, burning, itching, or peeling;




  • thinning of your skin;




  • blistering skin; or




  • stretch marks.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dermarest Plus Anti-Itch (hydrocortisone topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied hydrocortisone. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Dermarest Plus Anti-Itch resources


  • Dermarest Plus Anti-Itch Side Effects (in more detail)
  • Dermarest Plus Anti-Itch Use in Pregnancy & Breastfeeding
  • Dermarest Plus Anti-Itch Drug Interactions
  • Dermarest Plus Anti-Itch Support Group
  • 0 Reviews for Dermarest Plus Anti-Itch - Add your own review/rating


  • Ala-Cort Advanced Consumer (Micromedex) - Includes Dosage Information

  • Anusol-HC Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Carmol HC Prescribing Information (FDA)

  • Carmol HC MedFacts Consumer Leaflet (Wolters Kluwer)

  • Cortizone-10 Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Hydrocortisone Acetate Monograph (AHFS DI)

  • Hydrocortisone with Aloe Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Hytone Prescribing Information (FDA)

  • Instacort Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Locoid Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Locoid Lipocream Prescribing Information (FDA)

  • Locoid Lotion Prescribing Information (FDA)

  • Nutracort Lotion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Pandel Prescribing Information (FDA)

  • Pediaderm HC Lotion MedFacts Consumer Leaflet (Wolters Kluwer)

  • ProctoCream-HC Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Proctocort Prescribing Information (FDA)

  • Texacort Prescribing Information (FDA)

  • U-cort Prescribing Information (FDA)

  • Westcort Prescribing Information (FDA)



Compare Dermarest Plus Anti-Itch with other medications


  • Anal Itching
  • Aphthous Stomatitis, Recurrent
  • Atopic Dermatitis
  • Dermatitis
  • Eczema
  • Gingivitis
  • Proctitis
  • Pruritus
  • Psoriasis
  • Seborrheic Dermatitis
  • Skin Rash


Where can I get more information?


  • Your pharmacist can provide more information about hydrocortisone topical.

See also: Dermarest Plus Anti-Itch side effects (in more detail)


Friday 9 September 2011

Alfacaina




Alfacaina may be available in the countries listed below.


Ingredient matches for Alfacaina



Articaine

Articaine hydrochloride (a derivative of Articaine) is reported as an ingredient of Alfacaina in the following countries:


  • Italy

Epinephrine

Epinephrine is reported as an ingredient of Alfacaina in the following countries:


  • Italy

Epinephrine hydrochloride (a derivative of Epinephrine) is reported as an ingredient of Alfacaina in the following countries:


  • Italy

International Drug Name Search

Gabapentin Nycomed




Gabapentin Nycomed may be available in the countries listed below.


Ingredient matches for Gabapentin Nycomed



Gabapentin

Gabapentin is reported as an ingredient of Gabapentin Nycomed in the following countries:


  • Latvia

  • Lithuania

  • Sweden

International Drug Name Search

Thursday 8 September 2011

Synergic




Synergic may be available in the countries listed below.


Ingredient matches for Synergic



Cilastatin

Cilastatin is reported as an ingredient of Synergic in the following countries:


  • Tunisia

Imipenem

Imipenem is reported as an ingredient of Synergic in the following countries:


  • Tunisia

International Drug Name Search

Wednesday 7 September 2011

Clotrimazol HelvePharm




Clotrimazol HelvePharm may be available in the countries listed below.


Ingredient matches for Clotrimazol HelvePharm



Clotrimazole

Clotrimazole is reported as an ingredient of Clotrimazol HelvePharm in the following countries:


  • Switzerland

International Drug Name Search

Tuesday 6 September 2011

Prostam L.P.




Prostam L.P. may be available in the countries listed below.


Ingredient matches for Prostam L.P.



Tamsulosin

Tamsulosin is reported as an ingredient of Prostam L.P. in the following countries:


  • Tunisia

International Drug Name Search

Thursday 1 September 2011

PMS-Cholestyramine




PMS-Cholestyramine may be available in the countries listed below.


Ingredient matches for PMS-Cholestyramine



Colestyramine

Colestyramine is reported as an ingredient of PMS-Cholestyramine in the following countries:


  • Canada

  • Singapore

International Drug Name Search

Wednesday 31 August 2011

Azray




Azray may be available in the countries listed below.


Ingredient matches for Azray



Sodium Gualenate

Sodium Gualenate is reported as an ingredient of Azray in the following countries:


  • Japan

International Drug Name Search

Saturday 27 August 2011

Terbinafina Depronal




Terbinafina Depronal may be available in the countries listed below.


Ingredient matches for Terbinafina Depronal



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafina Depronal in the following countries:


  • Spain

International Drug Name Search

Friday 26 August 2011

Sulfacetamida




Sulfacetamida may be available in the countries listed below.


Ingredient matches for Sulfacetamida



Sulfacetamide Sodium

Sulfacetamide is reported as an ingredient of Sulfacetamida in the following countries:


  • Colombia

International Drug Name Search

Saturday 20 August 2011

Sevorane




Sevorane may be available in the countries listed below.


Ingredient matches for Sevorane



Sevoflurane

Sevoflurane is reported as an ingredient of Sevorane in the following countries:


  • Argentina

  • Australia

  • Austria

  • Belgium

  • Bosnia & Herzegowina

  • Brazil

  • Bulgaria

  • Canada

  • Chile

  • China

  • Costa Rica

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • France

  • Germany

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • Hungary

  • Iceland

  • Indonesia

  • Israel

  • Italy

  • Latvia

  • Lithuania

  • Luxembourg

  • Mexico

  • New Zealand

  • Nicaragua

  • Norway

  • Panama

  • Peru

  • Philippines

  • Poland

  • Romania

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • Spain

  • Sweden

  • Switzerland

  • Thailand

  • Tunisia

  • Turkey

  • Venezuela

International Drug Name Search

Monday 15 August 2011

Colchisol




Colchisol may be available in the countries listed below.


Ingredient matches for Colchisol



Colchicine

Colchicine is reported as an ingredient of Colchisol in the following countries:


  • Peru

International Drug Name Search

Sunday 14 August 2011

Sélégiline Biogaran




Sélégiline Biogaran may be available in the countries listed below.


Ingredient matches for Sélégiline Biogaran



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Sélégiline Biogaran in the following countries:


  • France

International Drug Name Search

Saturday 13 August 2011

Glioblastoma Multiforme Medications


Definition of Glioblastoma Multiforme: Primary brain tumor is a mass created by growth of abnormal cells or uncontrolled proliferation of cells in the brain.

Drugs associated with Glioblastoma Multiforme

The following drugs and medications are in some way related to, or used in the treatment of Glioblastoma Multiforme. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Glioblastoma Multiforme





Drug List:

Thursday 11 August 2011

Meridam




Meridam may be available in the countries listed below.


Ingredient matches for Meridam



Butenafine

Butenafine hydrochloride (a derivative of Butenafine) is reported as an ingredient of Meridam in the following countries:


  • Japan

International Drug Name Search

Monday 8 August 2011

Edrophonium Chloride




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000116-38-1

Chemical Formula

C10-H16-Cl-N-O

Molecular Weight

201

Therapeutic Categories

Antidote: Curare antagonist

Diagnostic agent

Chemical Name

Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride

Foreign Names

  • Edrophonii chloridum (Latin)
  • Edrophonium chlorid (German)
  • Chlorure d'edrophonium (French)
  • Cloruro de edrofonio (Spanish)

Generic Names

  • Edrophonium Chloride (OS: BAN)
  • Edrophoni chloridum (PH: Ph. Int. 2)
  • Edrophonii chloridum (PH: Ph. Int. 4, Ph. Eur. 6)
  • Edrophonium Chloride (PH: JP XV, Ph. Eur. 6, Ph. Int. 4, USP 32, BP 2010)

Brand Names

  • Antirex
    Kyorin, Japan


  • Edrophonium Chloride
    Hospira, United States


  • Enlon
    Baxter, Canada


  • Tensilon
    ICN, United States


  • Anticude
    Arafarma, Spain

International Drug Name Search

Glossary

BANBritish Approved Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 7 August 2011

Endotape




Endotape may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Endotape



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Endotape in the following countries:


  • South Africa

Praziquantel

Praziquantel is reported as an ingredient of Endotape in the following countries:


  • South Africa

International Drug Name Search

Friday 5 August 2011

Demerol



Pronunciation: me-PER-ih-deen
Generic Name: Meperidine
Brand Name: Demerol


Demerol is used for:

Short-term treatment of moderate to severe pain. It may also be used before or during surgery (eg, to support anesthesia), for pain relief during labor and delivery, or for other conditions as determined by your doctor.


Demerol is a narcotic analgesic. It works in the brain and nervous system to decrease pain.


Do NOT use Demerol if:


  • you are allergic to any ingredient in Demerol

  • you have severely slow or difficult breathing

  • you have taken a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

  • you are taking ritonavir, sibutramine, or sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Demerol:


Some medical conditions may interact with Demerol. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have had an allergic reaction to any codeine- or morphine-related medicine (eg, hydrocodone, oxycodone, dihydrocodeine, hydromorphone)

  • if you have a history of lung or breathing problems (eg, asthma, chronic obstructive pulmonary disease [COPD], cor pulmonale); low levels of oxygen or high levels of carbon dioxide in the blood; sickle cell anemia; adrenal gland problems (eg, Addison disease, pheochromocytoma); curvature of the spine (scoliosis); thyroid problems; low blood pressure; an enlarged prostate; urinary blockage or trouble urinating; lung, liver, or kidney problems; heart problems (eg, fast or irregular heartbeat); seizures; or stomach or bowels problems (eg, inflammatory bowel disease)

  • if you have or have recently had any head injury, brain tumor or other growths, or increased pressure in the brain

  • if you drink alcohol; are going through withdrawal from alcohol or other substances; or have a history of alcohol or substance abuse or dependence, mental or mood problems, or suicidal thoughts or attempts

  • if you have severe diarrhea due to taking an antibiotic (pseudomembranous colitis), constipation, stomach pain, low blood volume, dehydration, drowsiness, or severe weakness, or have had recent surgery

Some MEDICINES MAY INTERACT with Demerol. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Mixed narcotic agonist/antagonists (eg, butorphanol, pentazocine), naltrexone, or rifamycins (eg, rifampin) because they may decrease Demerol's effectiveness

  • Furazolidone or MAOIs (eg, phenelzine) because the risk of serious side effects, including coma, difficulty breathing, low blood pressure, seizures, and irregular heartbeat, may be increased

  • Selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) or sibutramine because the risk of side effects, including increased body temperature, mental or mood changes, muscle twitching, or severe drowsiness, may be increased

  • Acyclovir, cimetidine, phenothiazines (eg, chlorpromazine), phenytoin, or ritonavir because the risk of side effects of Demerol may be increased

  • Muscle relaxers (eg, cyclobenzaprine) or sodium oxybate (GHB) because actions and side effects may be increased by Demerol

This may not be a complete list of all interactions that may occur. Ask your health care provider if Demerol may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Demerol:


Use Demerol as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Demerol is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Demerol at home, a health care provider will teach you how to use it. Be sure you understand how to use Demerol. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Tell your doctor if you still experience pain or if your pain gets worse while using Demerol.

  • Do not use Demerol if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Demerol and you are using it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Demerol.



Important safety information:


  • Demerol may cause drowsiness, dizziness, or light-headedness. These effects may be worse if you take it with alcohol or certain medicines. Use Demerol with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Demerol may cause dizziness, light-headedness, or fainting; alcohol, hot weather, exercise, or fever can increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Demerol; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Demerol may cause constipation. Talk with your doctor or pharmacist about using a stool softener or laxative to prevent constipation. It is also important to maintain a diet adequate in fiber, drink plenty or water, and exercise to prevent constipation. If you become constipated while taking Demerol, talk with your doctor or pharmacist.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Prolonged use of Demerol may increase the risk of toxicity, including seizures.

  • Do not suddenly stop taking Demerol without first checking with your doctor. If you have been taking Demerol for more than a few weeks and your doctor tells you to stop taking it, your dose may need to be gradually lowered as directed by your doctor to avoid side effects.

  • Tell your doctor or dentist that you take Demerol before you receive any medical or dental care, emergency care, or surgery.

  • Use Demerol with caution in the ELDERLY; they may be more sensitive to its effects.

  • Use Demerol with extreme caution in CHILDREN; they may be more sensitive to its effects, especially slowed or difficult breathing.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Demerol while you are pregnant. Demerol is found in breast milk. Do not breast-feed while using Demerol.

When used for long periods of time or at high doses, Demerol may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Demerol stops working well. Do not take more than prescribed.


When used for long periods of time or at high doses, some people develop a need to continue taking Demerol. This is known as DEPENDENCE or addiction.


If you suddenly stop taking Demerol, you may experience WITHDRAWAL symptoms, including anxiety; appetite loss; backache; chills; diarrhea; enlarged pupils; fast heartbeat or breathing rate; increased tears; irritability; muscle or joint pain; nausea; restlessness; runny nose; severe or persistent dizziness; sleeplessness; stomach cramps; sweating; vomiting; weakness; and yawning.



Possible side effects of Demerol:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; dizziness; drowsiness; flushing; light-headedness; loss of appetite; nausea; sweating; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; confusion; difficulty urinating; fainting; fast, slow, or irregular heartbeat; hallucinations; mental or mood changes; numbness of an arm or a leg; seizure; severe or persistent constipation or stomach pain; severe or persistent dizziness or light-headedness; slowed, shallow, or difficult breathing; sudden severe headache, nausea, or vomiting; tremor; uncontrolled muscle movements; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Demerol side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include chest pain; cold and clammy skin; fainting; limp muscles; loss of consciousness; low body temperature; seizures; severe dizziness or light-headedness; severe drowsiness; slowed heartbeat; slowed, shallow, or difficult breathing; small pupils.


Proper storage of Demerol:

Demerol is usually handled and stored by a health care provider. If you are using Demerol at home, store Demerol as directed by your pharmacist or health care provider. Keep Demerol out of the reach of children and away from pets.


General information:


  • If you have any questions about Demerol, please talk with your doctor, pharmacist, or other health care provider.

  • Demerol is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Demerol. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Demerol resources


  • Demerol Side Effects (in more detail)
  • Demerol Use in Pregnancy & Breastfeeding
  • Drug Images
  • Demerol Drug Interactions
  • Demerol Support Group
  • 34 Reviews for Demerol - Add your own review/rating


Compare Demerol with other medications


  • Light Sedation
  • Pain

Thursday 4 August 2011

Trifluopérazine




Trifluopérazine may be available in the countries listed below.


Ingredient matches for Trifluopérazine



Trifluoperazine

Trifluopérazine (DCF) is known as Trifluoperazine in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 25 July 2011

STPase




STPase may be available in the countries listed below.


Ingredient matches for STPase



Streptokinase

Streptokinase is reported as an ingredient of STPase in the following countries:


  • Bulgaria

  • Latvia

International Drug Name Search

Sunday 24 July 2011

Doxycyclin Tabs Sandoz




Doxycyclin Tabs Sandoz may be available in the countries listed below.


Ingredient matches for Doxycyclin Tabs Sandoz



Doxycycline

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin Tabs Sandoz in the following countries:


  • Germany

International Drug Name Search

Friday 22 July 2011

Lanx




Lanx may be available in the countries listed below.


Ingredient matches for Lanx



Spironolactone

Spironolactone is reported as an ingredient of Lanx in the following countries:


  • Argentina

International Drug Name Search

Thursday 21 July 2011

Sandoz Citalopram




Sandoz Citalopram may be available in the countries listed below.


Ingredient matches for Sandoz Citalopram



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Sandoz Citalopram in the following countries:


  • Canada

  • South Africa

International Drug Name Search

Saturday 16 July 2011

Calcio Cloruro Salf




Calcio Cloruro Salf may be available in the countries listed below.


Ingredient matches for Calcio Cloruro Salf



Calcium Chloride

Calcium Chloride dihydrate (a derivative of Calcium Chloride) is reported as an ingredient of Calcio Cloruro Salf in the following countries:


  • Italy

International Drug Name Search

Saturday 9 July 2011

Bestalin




Bestalin may be available in the countries listed below.


Ingredient matches for Bestalin



Hydroxyzine

Hydroxyzine hydrochloride (a derivative of Hydroxyzine) is reported as an ingredient of Bestalin in the following countries:


  • Indonesia

International Drug Name Search

Friday 8 July 2011

ratio-Pioglitazone




ratio-Pioglitazone may be available in the countries listed below.


Ingredient matches for ratio-Pioglitazone



Pioglitazone

Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of ratio-Pioglitazone in the following countries:


  • Canada

International Drug Name Search

Latisse




In the US, Latisse (bimatoprost topical) is a member of the drug class miscellaneous topical agents and is used to treat Eyelash Hypotrichosis.

US matches:

  • Latisse

Ingredient matches for Latisse



Bimatoprost

Bimatoprost is reported as an ingredient of Latisse in the following countries:


  • United States

International Drug Name Search

Etopophos




In the US, Etopophos (etoposide systemic) is a member of the drug class mitotic inhibitors and is used to treat Cancer, Hodgkin's Lymphoma, Ovarian Cancer, Small Cell Lung Cancer and Testicular Cancer.

US matches:

  • Etopophos

UK matches:

  • Etopophos 100mg Powder for Solution for Injection (SPC)

Ingredient matches for Etopophos



Etoposide

Etoposide phospate (a derivative of Etoposide) is reported as an ingredient of Etopophos in the following countries:


  • Australia

  • Bahrain

  • Chad

  • Cote D'ivoire

  • Egypt

  • France

  • Gabon

  • Germany

  • Guinea

  • Iran

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Luxembourg

  • Mali

  • New Zealand

  • Niger

  • Oman

  • Qatar

  • Saudi Arabia

  • Senegal

  • South Africa

  • Switzerland

  • Syria

  • Togo

  • United Arab Emirates

  • United Kingdom

  • United States

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.